Skip to main content
Clinical Trials/CTRI/2018/04/012946
CTRI/2018/04/012946
Completed
未知

A prospective, observational study to evaluate the efficacy,safety of AKBBA capsules & topical cream for the management of plaque type psoriasis.

Sami Labs Limited0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Adult male or female patients with mild to moderate plaque type psoriasis.
Sponsor
Sami Labs Limited
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 10, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Sami Labs Limited

Eligibility Criteria

Inclusion Criteria

  • 1 Patients with Mild to Moderate plaque type psoriasis excluding co\-morbid conditions.
  • 2 Chronic plaque type psoriasis or stable psoriasis.
  • 3 Willing to sign on Informed consent form.

Exclusion Criteria

  • 1 Patients who have more than 50 percent of body surface area covered by psoriasis lesions.
  • 2 Patients on anticoagulant therapy.
  • 3 Use of immunosuppressive medication within past 2 months.
  • 4 Presence of other skin lesions (actinic ketoses or lentigo) or photo damaged skin
  • 5 Use of systemic or intra lesional therapy or photo (chemo) therapy for psoriasis in the previous two months.
  • 6 Concomitant bacterial, fungal, or viral skin infections.
  • 7 Pregnant or sexually active women who do not use contraception.
  • 8 Non\-adherence to the treatment.
  • 9 Have history of renal, hepatobiliary, or malignant disease, hypertension or recurrent acute infection
  • 10 History of any other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials